ArticleFrontiers in immunology2026

Clinical characteristics of immune-related adverse events after immune checkpoint inhibitor therapy with or without chemotherapy in patients with antinuclear antibody-positive malignancies.

Hanghui Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.